Gerald L. Ray & Associates’s Zimmer Biomet ZBH Stock Holding History

Gerald L. Ray & Associates’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$783K	Hold	6,891	–	–	0.1%	175
2017 Q2	$859K	Sell	6,891 -206	-3%	-$24.4K	0.11%	169
2017 Q1	$841K	Sell	7,097 -77	-1%	-$8.73K	0.12%	163
2016 Q4	$719K	Hold	7,174	–	–	0.1%	174
2016 Q3	$906K	Hold	7,174	–	–	0.14%	143
2016 Q2	$839K	Hold	7,174	–	–	0.13%	137
2016 Q1	$743K	Hold	7,174	–	–	0.12%	149
2015 Q4	$714K	Hold	7,174	–	–	0.11%	159
2015 Q3	$655K	Hold	7,174	–	–	0.11%	163
2015 Q2	$761K	Hold	7,174	–	–	0.12%	160
2015 Q1	$819K	Buy	7,174 +1,519	+27%	+$173K	0.12%	153
2014 Q4	$622K	Buy	5,655 +31	+0.6%	+$3.27K	0.1%	178
2014 Q3	$549K	Hold	5,624	–	–	0.09%	186
2014 Q2	$567K	Hold	5,624	–	–	0.1%	175
2014 Q1	$516K	Hold	5,624	–	–	0.09%	173
2013 Q4	$509K	Hold	5,624	–	–	0.1%	171
2013 Q3	$449K	Hold	5,624	–	–	0.09%	174
2013 Q2	$409K	Buy	+5,624	New	+$421K	0.09%	175

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gerald L. Ray & Associates's ZBH Position: Q3 2017 in Review

Gerald L. Ray & Associates held its Zimmer Biomet (ZBH) position steady in Q3 2017 at 6,891 shares worth $783K. The position accounts for 0.1% of the portfolio, ranked #175.

Gerald L. Ray & Associates first reported a position in ZBH in Q2 2013 and has held it in 18 quarters since. The position peaked at $906K in Q3 2016. 818 funds tracked by Wall St. Rank hold ZBH as of Q3 2017.

Gerald L. Ray & Associates held 6,891 shares of Zimmer Biomet worth $783K as of Q3 2017.
Gerald L. Ray & Associates left its Zimmer Biomet share count unchanged in Q3 2017.
Zimmer Biomet made up 0.1% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #175 holding.
Gerald L. Ray & Associates first reported a position in Zimmer Biomet in Q2 2013 and has held it in 18 quarters since.
Gerald L. Ray & Associates's Zimmer Biomet position peaked at $906K in Q3 2016.
818 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.